	US 11,813,291 B2
	Ready-to-use potassium phosphates in sodium chloride solutions
Brijeshkumar B. Pandya, Sacramento, CA (US); Govind R. Jagadale, Sacramento, CA (US); Dasaradhi Lakkaraju, Sacramento, CA (US); Bala Tripura Sundari Chodavarapu, Davis, CA (US); Anand Shukla, Denver, CO (US); and Jwalant Shukla, Sacramento, CA (US)
Assigned to NIVAGEN PHARMACEUTICALS, INC., Sacramento, CA (US)
Filed by Nivagen Pharmaceuticals, Inc., Sacramento, CA (US)
Filed on Oct. 12, 2021, as Appl. No. 17/499,001.
Claims priority of provisional application 63/090,518, filed on Oct. 12, 2020.
Prior Publication US 2022/0110969 A1, Apr. 14, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 33/42 (2006.01); A61K 9/08 (2006.01); A61M 39/02 (2006.01); A61M 5/168 (2006.01)

CPC A61K 33/42 (2013.01) [A61K 9/08 (2013.01); A61M 5/168 (2013.01); A61M 39/0208 (2013.01)]

20 Claims

1. An isotonic sterile ready-to-use aqueous potassium phosphates solution, comprising potassium phosphates and sodium chloride, wherein the solution comprises 15 mmol/100 ml phosphorus and equal or less than 50 mcg/L aluminum.